145 related articles for article (PubMed ID: 31524685)
1. Selective Internal Radiation Therapy for Liver Metastasis of Papillary Thyroid Carcinoma.
Kesim S; Ones T; Ozguven S; Dulundu E; Baltacioglu F
Clin Nucl Med; 2020 Jan; 45(1):76-77. PubMed ID: 31524685
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of malignant fluorodeoxyglucose-avid lymph node on preablation positron emission tomography in patients with papillary thyroid cancer undergoing radioiodine ablation therapy.
Cho SG; Kwon SY; Kim J; Cho DH; Na MH; Kang SR; Yoo SW; Song HC
Medicine (Baltimore); 2019 Apr; 98(16):e14858. PubMed ID: 31008921
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic metastasis from papillary thyroid carcinoma: Case report and literature review.
Stein R; Harmon TS; Harmon CE; Kuo E; Ozdemir S
Hell J Nucl Med; 2021; 24(2):140-148. PubMed ID: 34352049
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Mosci C; McDougall IR; Jeffrey RB; Iagaru A
Clin Nucl Med; 2012 Sep; 37(9):e234-6. PubMed ID: 22889801
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.
Samanci C; Onal Y; Sager S; Asa S; Ustabasioglu FE; Alis D; Akman C; Sonmezoglu K
Curr Med Imaging Rev; 2019; 15(10):956-964. PubMed ID: 32008523
[TBL] [Abstract][Full Text] [Related]
6. An intrapericardial ectopic thyroid mimicking metastasis in a patient with papillary thyroid cancer: Localization, differential diagnosis by
Park SH; Seo M; Park TY; Nam-Goong S
Hell J Nucl Med; 2016; 19(3):272-274. PubMed ID: 27824968
[TBL] [Abstract][Full Text] [Related]
7. Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET.
Lin M; Shon IH; Wilson R; D'Amours SK; Schlaphoff G; Lin P
Hepatogastroenterology; 2007; 54(75):910-2. PubMed ID: 17591090
[TBL] [Abstract][Full Text] [Related]
8. F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
Hung MC; Wu HS; Kao CH; Chen WK; Changlai SP
Endocr Res; 2003 May; 29(2):169-75. PubMed ID: 12856803
[TBL] [Abstract][Full Text] [Related]
9. Concordant F-18 FDG PET and Y-90 Bremsstrahlung scans depict selective delivery of Y-90-microspheres to liver tumors: confirmation with histopathology.
Tehranipour N; AL-Nahhas A; Canelo R; Stamp G; Woo K; Tait P; Gishen P
Clin Nucl Med; 2007 May; 32(5):371-4. PubMed ID: 17452865
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
Haug AR; Tiega Donfack BP; Trumm C; Zech CJ; Michl M; Laubender RP; Uebleis C; Bartenstein P; Heinemann V; Hacker M
J Nucl Med; 2012 Mar; 53(3):371-7. PubMed ID: 22331219
[TBL] [Abstract][Full Text] [Related]
11. Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver metastases.
Bienert M; McCook B; Carr BI; Geller DA; Sheetz M; Amesur N; Avril N
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):723. PubMed ID: 15599525
[No Abstract] [Full Text] [Related]
12. Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease.
Turkmen C; Ucar A; Poyanli A; Vatankulu B; Ozkan G; Basaran M; Serin K; Sanli Y; Adalet I
Cancer Biother Radiopharm; 2013 Sep; 28(7):534-40. PubMed ID: 23647219
[TBL] [Abstract][Full Text] [Related]
13. Two Cases of Synchronous Hodgkin Lymphoma and Papillary Thyroid Carcinoma in 18 F-FDG PET/CT.
Wang R; Cai H; Liu C; Lv Z; Ma C
Clin Nucl Med; 2024 Jul; 49(7):650-651. PubMed ID: 38689445
[TBL] [Abstract][Full Text] [Related]
14. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma.
Kim MH; Ko SH; Bae JS; Lee SH; Jung CK; Lim DJ; Baek KH; Kim SH; Lee JM; Kang MI; Cha BY
Thyroid; 2013 Nov; 23(11):1452-60. PubMed ID: 23688271
[TBL] [Abstract][Full Text] [Related]
15. Extensive lymph node metastases found by (18)F-FDG-PET/CT in a patient with diffuse sclerosing variant of papillary thyroid carcinoma.
Xu YH; Song HJ; Qiu ZL; Luo QY
Hell J Nucl Med; 2011; 14(2):188-9. PubMed ID: 21761030
[No Abstract] [Full Text] [Related]
16. 90Y Liver Radioembolization Imaging Using Amplitude-Based Gated PET/CT.
Osborne DR; Acuff S; Neveu M; Kaman A; Syed M; Fu Y
Clin Nucl Med; 2017 May; 42(5):373-374. PubMed ID: 28240669
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
[TBL] [Abstract][Full Text] [Related]
18. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
20. Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
Wong CY; Gates VL; Tang B; Campbell J; Qing F; Lewandowski RJ; Thie J; Ho CL; Savin M; Salem R
Cancer Biother Radiopharm; 2010 Apr; 25(2):233-6. PubMed ID: 20423237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
